2021 CHEST指南:静脉血栓栓塞(VTE)的抗栓治疗(第2次更新)

2021-12-02 美国胸科医师学会 Chest

2021年,美国胸科医师学会(ACCP)对静脉血栓栓塞(VTE)的抗栓治疗指南进行2次更新,本文就17个PICO问题提出了指导建议。

中文标题:

2021 CHEST指南:静脉血栓栓塞(VTE)的抗栓治疗(第2次更新)

英文标题:

Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report

发布机构:

美国胸科医师学会

发布日期:

2021-12-02

简要介绍:

2021年,美国胸科医师学会(ACCP)对静脉血栓栓塞(VTE)的抗栓治疗指南进行2次更新,本文就17个PICO问题提出了指导建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 CHEST指南:静脉血栓栓塞(VTE)的抗栓治疗(第2次更新).pdf)] GetToolGuiderByIdResponse(projectId=1, id=052771c00228e970, title=2021 CHEST指南:静脉血栓栓塞(VTE)的抗栓治疗(第2次更新), enTitle=Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report, guiderFrom=Chest, authorId=0, author=, summary=2021年,美国胸科医师学会(ACCP)对静脉血栓栓塞(VTE)的抗栓治疗指南进行2次更新,本文就17个PICO问题提出了指导建议。, cover=, journalId=0, articlesId=null, associationId=180, associationName=美国胸科医师学会, associationIntro=提供胸科疾病指南, 《chest》是美国胸科医师学会旗下期刊。, copyright=0, guiderPublishedTime=Thu Dec 02 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年,美国胸科医师学会(ACCP)对静脉血栓栓塞(VTE)的抗栓治疗指南进行2次更新,本文就17个PICO问题提出了指导建议。</span></p>, tagList=[], categoryList=[CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=92, categoryName=血管外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7960, appHits=818, showAppHits=0, pcHits=2010, showPcHits=7141, likes=4, shares=104, comments=26, approvalStatus=1, publishedTime=Fri Dec 10 12:03:48 CST 2021, publishedTimeString=2021-12-02, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Thu Dec 09 18:17:56 CST 2021, updatedBy=6415643, updatedName=凯晨, updatedTime=Sat Jan 06 22:36:33 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 CHEST指南:静脉血栓栓塞(VTE)的抗栓治疗(第2次更新).pdf)])
2021 CHEST指南:静脉血栓栓塞(VTE)的抗栓治疗(第2次更新).pdf
下载请点击:
评论区 (18)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2154851, encodeId=c30c21548518f, content=血栓治疗指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34178826963, createdName=不将就的山药药, createdTime=Sun Aug 27 22:29:59 CST 2023, time=2023-08-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1199439, encodeId=c8a51199439fa, content=最新指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a6d6534121, createdName=ms3000000452816472, createdTime=Fri Mar 04 17:40:15 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196815, encodeId=6412119681571, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Thu Feb 24 14:01:37 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185073, encodeId=8f2b11850e3b2, content=学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=328f52344, createdName=khust1986, createdTime=Mon Jan 17 07:26:06 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192358, encodeId=a9fc11923582e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41b65626693, createdName=ms6000002070683938, createdTime=Fri Feb 11 15:53:49 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2023-08-27 不将就的山药药 来自四川省

    血栓治疗指南

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2154851, encodeId=c30c21548518f, content=血栓治疗指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34178826963, createdName=不将就的山药药, createdTime=Sun Aug 27 22:29:59 CST 2023, time=2023-08-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1199439, encodeId=c8a51199439fa, content=最新指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a6d6534121, createdName=ms3000000452816472, createdTime=Fri Mar 04 17:40:15 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196815, encodeId=6412119681571, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Thu Feb 24 14:01:37 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185073, encodeId=8f2b11850e3b2, content=学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=328f52344, createdName=khust1986, createdTime=Mon Jan 17 07:26:06 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192358, encodeId=a9fc11923582e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41b65626693, createdName=ms6000002070683938, createdTime=Fri Feb 11 15:53:49 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2022-03-04 ms3000000452816472

    最新指南

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2154851, encodeId=c30c21548518f, content=血栓治疗指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34178826963, createdName=不将就的山药药, createdTime=Sun Aug 27 22:29:59 CST 2023, time=2023-08-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1199439, encodeId=c8a51199439fa, content=最新指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a6d6534121, createdName=ms3000000452816472, createdTime=Fri Mar 04 17:40:15 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196815, encodeId=6412119681571, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Thu Feb 24 14:01:37 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185073, encodeId=8f2b11850e3b2, content=学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=328f52344, createdName=khust1986, createdTime=Mon Jan 17 07:26:06 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192358, encodeId=a9fc11923582e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41b65626693, createdName=ms6000002070683938, createdTime=Fri Feb 11 15:53:49 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2022-02-24 huihui0728

    学习一下

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2154851, encodeId=c30c21548518f, content=血栓治疗指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34178826963, createdName=不将就的山药药, createdTime=Sun Aug 27 22:29:59 CST 2023, time=2023-08-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1199439, encodeId=c8a51199439fa, content=最新指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a6d6534121, createdName=ms3000000452816472, createdTime=Fri Mar 04 17:40:15 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196815, encodeId=6412119681571, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Thu Feb 24 14:01:37 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185073, encodeId=8f2b11850e3b2, content=学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=328f52344, createdName=khust1986, createdTime=Mon Jan 17 07:26:06 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192358, encodeId=a9fc11923582e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41b65626693, createdName=ms6000002070683938, createdTime=Fri Feb 11 15:53:49 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2022-01-17 khust1986

    学习!

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2154851, encodeId=c30c21548518f, content=血栓治疗指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34178826963, createdName=不将就的山药药, createdTime=Sun Aug 27 22:29:59 CST 2023, time=2023-08-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1199439, encodeId=c8a51199439fa, content=最新指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a6d6534121, createdName=ms3000000452816472, createdTime=Fri Mar 04 17:40:15 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196815, encodeId=6412119681571, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Thu Feb 24 14:01:37 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185073, encodeId=8f2b11850e3b2, content=学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=328f52344, createdName=khust1986, createdTime=Mon Jan 17 07:26:06 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192358, encodeId=a9fc11923582e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41b65626693, createdName=ms6000002070683938, createdTime=Fri Feb 11 15:53:49 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2022-02-11 ms6000002070683938

    学习

    0